News

The multicenter, double-blind, randomized, placebo-controlled Phase I study was designed to assess the safety and immunogenicity – a patient’s ability to generate an immune response – of four

This Phase II randomized study enrolled 253 patients with postsurgical pain. Three doses of ARRY-797 (200mg, 400mg and 600mg) were compared to placebo and celecoxib (400mg). In the

Results from the 50-patient placebo-controlled trial demonstrated that three of the four doses of INCB18424 evaluated (15mg BID, 25mg BID and 50mg QD) produced impressive clinical benefits and

AI-525 is a preclinical-stage injectable formulation of celecoxib using Acusphere’s proprietary Hydrophobic Drug Delivery System technology. The transaction is expected to close in approximately 10 days. The $15

Pitavastatin is a novel ‘statin’ for the treatment of hypercholesterolaemia. The request for approval dossier was submitted by Kowa Pharmaceutical Europe (KPE) at the end of August 2008

Previously, the company announced that the US Phase II clinical trial had been suspended in order to investigate an incident of post-operative bleeding. This event met the stopping

The terms of the proposed offer were not disclosed but include a stock for stock exchange and the assumption of liabilities with a potential total deal value in

The Ring trial is a randomized, double-blind, placebo-controlled study evaluating approximately 200 patients with refractory gastrointestinal stromal tumors (GIST) in over 20 countries and 50 sites worldwide. Patients

The lawsuit is based upon an abbreviated new drug application (ANDA) filed by Barr requesting approval to market and sell a generic version of Oxytrol to be sold